Generics Deliver Value. Still.

Aug 7, 2017
By negotiating with drug makers on behalf of 83 million Americans, we have better leverage to reduce generic prescription drug prices for patients.

New Pill Bottle

Generic medications continue to deliver significant cost savings by providing cost-effective alternatives to brand name medications.

According to the Express Scripts Prescription Price Index, the average price for the most commonly used brand-name drugs has increased 208% since 2008, while generic drug prices overall have declined.

PPI 2016 

Express Scripts’ generic fill rate averages 85.4%. In some therapy classes, it’s greater than 90%.

Yet, there is still opportunity for payers and members to ensure cost savings by achieving higher generic fill rates. Approximately 70% of pharmacy spending is for branded medications, with unsustainable year-over-year price increases.

Scale Matters

By negotiating with drug makers on behalf of 83 million Americans, we have better leverage to reduce generic prescription drug prices for patients. This contributes to the tremendous amount of competition and pressure among generic pharmaceutical manufacturers to provide better pricing.

Creating Headroom

Greater generic usage helps create headroom for payers to afford new breakthrough medicines that are often very expensive. In the same way, we expect that biosimilars will usher in a wave of savings on complex specialty medicines and will help expand access to care.

Author Bio

Lab Staff
comments powered by Disqus